Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H P Deigner

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Current Molecular Medicine|March 4, 2010
Challenges in mass spectrometry based targeted metabolomicsT Koal, H-P Deigner
Current Medicinal Chemistry|April 2, 1999
Modulating apoptosis: current applications and prospects for future drug developmentH P Deigner, R Kinscherf
FEBS Letters|May 6, 1996
Stimulation of mitogen activated protein kinase by LDL and oxLDL in human U-937 macrophage-like cellsH P Deigner, R Claus
Arzneimittel-Forschung|February 1, 1988
[Biotransformation of 4-oxa-5-exo-(N-methylcarbamoyloxy)-tricyclo-[5.2.1.0-2, 6endo] dec-8-en-3one in the rat]R Neidlein, H P Deigner
Chemistry and Physics of Lipids|April 1, 1992
Rapid synthesis of 2-desoxy-2-amino-3-phosphocholine-glycerinic-acid- alkylester, 1-alkyl-1-desoxy- and 1-O-alkyl-2-desoxy-2-amino-sn-glycero-3- phosphocholines, -3-phospho-N,N'-dimethylethanolamine and -3-phospho-Fmoc- serine-methylesterH P Deigner, B Fyrnys
Arzneimittel-Forschung|March 1, 1988
[Pharmacokinetics of 4-oxa-5-exo-(N-methylcarbamoyloxy)-tricyclo- [5.2.1.0. 2,6-endo] dec-8-en-3-one in the rat]R Neidlein, H P Deigner
FEBS Letters|February 15, 1993
Effect of platelet activating factor on the kinetics of LDL oxidation in vitroH P Deigner, H A Dresel
FEBS Letters|January 2, 1995
Susceptibility of phospholipids of oxidizing LDL to enzymatic hydrolysis modulates uptake by P388D1 macrophage-like cellsB Fyrnys, C Blencowe, H P Deigner
Expert Opinion on Investigational Drugs|November 4, 2000
Apoptosis modulators in the therapy of neurodegenerative diseasesH P Deigner, U Haberkorn, R Kinscherf
Arzneimittel-Forschung|March 1, 1995
Distribution and excretion of [14C]-labelled [2,2-dimethyl-6-(4-chlorophenyl)-7-phenyl-2,3-dihydro-1H-pyrrolizine-5- yl]- [2'-14C]-acetic acid in ratsH P Deigner, C E Freyberg, S Laufer
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Current Molecular Medicine|March 4, 2010
Challenges in mass spectrometry based targeted metabolomicsT Koal, H-P Deigner
Current Medicinal Chemistry|April 2, 1999
Modulating apoptosis: current applications and prospects for future drug developmentH P Deigner, R Kinscherf
FEBS Letters|May 6, 1996
Stimulation of mitogen activated protein kinase by LDL and oxLDL in human U-937 macrophage-like cellsH P Deigner, R Claus
Arzneimittel-Forschung|February 1, 1988
[Biotransformation of 4-oxa-5-exo-(N-methylcarbamoyloxy)-tricyclo-[5.2.1.0-2, 6endo] dec-8-en-3one in the rat]R Neidlein, H P Deigner
Chemistry and Physics of Lipids|April 1, 1992
Rapid synthesis of 2-desoxy-2-amino-3-phosphocholine-glycerinic-acid- alkylester, 1-alkyl-1-desoxy- and 1-O-alkyl-2-desoxy-2-amino-sn-glycero-3- phosphocholines, -3-phospho-N,N'-dimethylethanolamine and -3-phospho-Fmoc- serine-methylesterH P Deigner, B Fyrnys
Arzneimittel-Forschung|March 1, 1988
[Pharmacokinetics of 4-oxa-5-exo-(N-methylcarbamoyloxy)-tricyclo- [5.2.1.0. 2,6-endo] dec-8-en-3-one in the rat]R Neidlein, H P Deigner
FEBS Letters|February 15, 1993
Effect of platelet activating factor on the kinetics of LDL oxidation in vitroH P Deigner, H A Dresel
FEBS Letters|January 2, 1995
Susceptibility of phospholipids of oxidizing LDL to enzymatic hydrolysis modulates uptake by P388D1 macrophage-like cellsB Fyrnys, C Blencowe, H P Deigner
Expert Opinion on Investigational Drugs|November 4, 2000
Apoptosis modulators in the therapy of neurodegenerative diseasesH P Deigner, U Haberkorn, R Kinscherf
Arzneimittel-Forschung|March 1, 1995
Distribution and excretion of [14C]-labelled [2,2-dimethyl-6-(4-chlorophenyl)-7-phenyl-2,3-dihydro-1H-pyrrolizine-5- yl]- [2'-14C]-acetic acid in ratsH P Deigner, C E Freyberg, S Laufer
Pageof 4